KR101356799B1 - Natural preservative composition containing the extract of Tabebuia avellanedae, Smilax chian L., Rumex japonicus and Agastache rugosa - Google Patents
Natural preservative composition containing the extract of Tabebuia avellanedae, Smilax chian L., Rumex japonicus and Agastache rugosa Download PDFInfo
- Publication number
- KR101356799B1 KR101356799B1 KR1020120053031A KR20120053031A KR101356799B1 KR 101356799 B1 KR101356799 B1 KR 101356799B1 KR 1020120053031 A KR1020120053031 A KR 1020120053031A KR 20120053031 A KR20120053031 A KR 20120053031A KR 101356799 B1 KR101356799 B1 KR 101356799B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- natural
- preservative composition
- test example
- yangje
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 119
- 239000003755 preservative agent Substances 0.000 title claims abstract description 91
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- 230000002335 preservative effect Effects 0.000 title claims abstract description 69
- 240000004510 Agastache rugosa Species 0.000 title 1
- 235000010686 Agastache rugosa Nutrition 0.000 title 1
- 244000189123 Rumex japonicus Species 0.000 title 1
- 235000005247 Rumex japonicus Nutrition 0.000 title 1
- 241000362909 Smilax <beetle> Species 0.000 title 1
- 241001530102 Tabebuia Species 0.000 title 1
- 229930187284 avellanedae Natural products 0.000 title 1
- 239000002131 composite material Substances 0.000 claims abstract description 28
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 27
- 239000002537 cosmetic Substances 0.000 claims abstract description 24
- 235000013305 food Nutrition 0.000 claims abstract description 9
- 230000000845 anti-microbial effect Effects 0.000 abstract description 29
- 239000003814 drug Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000006071 cream Substances 0.000 description 22
- 238000009472 formulation Methods 0.000 description 22
- 230000000813 microbial effect Effects 0.000 description 20
- 230000002401 inhibitory effect Effects 0.000 description 18
- 230000002829 reductive effect Effects 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 14
- 241000588724 Escherichia coli Species 0.000 description 14
- 241000233866 Fungi Species 0.000 description 14
- 241000192125 Firmicutes Species 0.000 description 10
- 241000191967 Staphylococcus aureus Species 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 239000002609 medium Substances 0.000 description 9
- 241000228245 Aspergillus niger Species 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 7
- 206010040880 Skin irritation Diseases 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 230000003013 cytotoxicity Effects 0.000 description 7
- 231100000135 cytotoxicity Toxicity 0.000 description 7
- 230000002538 fungal effect Effects 0.000 description 7
- 231100000475 skin irritation Toxicity 0.000 description 7
- 230000036556 skin irritation Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241000480567 Pseudomonas aeruginosa C Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000009422 growth inhibiting effect Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- -1 p-hydroxybenzoic acid ester Chemical class 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000003359 percent control normalization Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000004734 cutaneous carcinogenesis Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 231100000507 endocrine disrupting Toxicity 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- SDPBXXCJVDQPIQ-UHFFFAOYSA-N hexadecyl hexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC SDPBXXCJVDQPIQ-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- MGIYRDNGCNKGJU-UHFFFAOYSA-N isothiazolinone Chemical compound O=C1C=CSN1 MGIYRDNGCNKGJU-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012577 media supplement Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- JUJBNYBVVQSIOU-UHFFFAOYSA-M sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=N1 JUJBNYBVVQSIOU-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3472—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/10—Preserving against microbes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물을 함유하는 천연 복합 방부제 조성물에 관한 것이다.
본 발명의 천연 복합 방부제 조성물은 인체에 독성이 없으며 뛰어난 방부효과 및 항균 효과를 가지고 있어, 합성 방부제 대신 화장품, 식품 및 의약품의 천연 방부제로 사용될 수 있다. The present invention relates to a natural complex preservative composition containing the Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje-Geun extract.
The natural composite preservative composition of the present invention is not toxic to the human body and has an excellent antiseptic and antimicrobial effect, and can be used as a natural preservative in cosmetics, foods and medicines instead of synthetic preservatives.
Description
본 발명은 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물을 함유하는 천연 복합 방부제 조성물에 관한 것이다.
The present invention relates to a natural complex preservative composition containing the Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje-Geun extract.
방부제는 화장품, 의약품, 생활용품, 식품 등 다양한 제품군의 품질을 장기간 유지하기 위해 필수적이며, 특히 유통기간이 비교적 길고 기름이나 물이 주성분으로 구성되어 있으며 미생물의 탄소원이 되는 글리세린이나 솔비톨 등과 질소원이 되는 아미노산 유도체 및 단백질 등으로 조성된 화장품의 경우는 더욱 필수적이다.Preservatives are essential to maintain the quality of various products such as cosmetics, medicines, household goods, and foods for a long time. Especially, the preservatives have a long shelf life and consist mainly of oil or water, and they are nitrogen sources such as glycerin or sorbitol, which are carbon sources of microorganisms. In the case of cosmetics composed of amino acid derivatives, proteins and the like is more essential.
화장품은 일반적으로 상온 1년~ 3년간의 유통기간을 가지고 있으며, 개봉 후 지속적으로 손과의 접촉으로 인하여 미생물에 매우 취약하다. 따라서 이러한 미생물로부터의 오염을 차단하며 제품의 안전과 품질을 보장하기 위하여 방부력이 높은 방부제를 사용해야 한다. Cosmetics generally have a shelf life of 1 to 3 years at room temperature and are very vulnerable to microorganisms due to continuous contact with hands after opening. Therefore, high preservatives should be used to block the contamination from these microorganisms and to ensure the safety and quality of the product.
하지만 기존의 화장품용 방부제는 화학적 방법에 의해서 제조된 화학방부제가 대부분이다. 이러한 화학방부제는 인체 피부에 장기적으로 사용되는 경우 피부 노화 촉진, 피부 자극, 발암 및 내분비계의 교란시킬 수 있는 문제점과 생분해성 결여 등의 문제점이 있어 인체에 안정하며, 환경친화적인 천연물 유래의 방부제의 개발이 필요하다.However, conventional cosmetic preservatives are mostly chemical preservatives prepared by chemical methods. These chemical preservatives are stable to the human body due to problems such as promoting skin aging, skin irritation, carcinogenesis, and endocrine disruption and lack of biodegradation when used in human skin for a long time. Development is needed.
또한, 대표적인 방부제인 파라벤(paraben, p-hydroxybenzoic acid ester), 포름알데하이드 도너(formaldehyde-donor) 및 이소티아졸리논(isothiazolinone) 등은 피부 알러지, 환경 호르몬으로서의 작용 가능성(Andera Countti et al ., Contact Dermatitis , 37:35, 1997; Edwin et al ., Toxicology and Applied Pharmacology, 153:12, 1998) 및 지속적인 체내 축척으로 인한 급, 만성 독성 및 돌연변이 유발 등의 유해성이 널리 인식되고 있기 때문에 일부 생산기업들은 소비자의 요구에 대응하여 대체 방부제 개발에 노력을 하고 있다. In addition, typical preservatives such as paraben (p-hydroxybenzoic acid ester), formaldehyde-donor and isothiazolinone are potential skin allergies and environmental hormones (Andera Countti et. al ., Contact Dermatitis , 37:35, 1997; Edwin meat al ., Toxicology and Applied Pharmacology , 153: 12, 1998) and the risks of rapid, chronic toxicity, and mutagenesis from persistent body scale are widely recognized and some producers are working to develop alternative preservatives in response to consumer needs.
이러한 문제점들로 인하여 제품의 안전성과 경제성이 우수한 천연방부제에 대한 연구가 지속되고 있으며 그 결과로 향신료, 정유, 한약재 등 동·식물기원의 추출물(한국등록특허 제10-09862490호, 제10-07876340호, 제10-07825990호, 제10-09814070호, 제10-07298310호, 제10-0822416호, 제10-09428300호, 한국공개특허 제2009-0025654호, 제2007-0080707호 및 제 2009-0075282호)과 박테리오신 같은 미생물 기원의 천연 항균성 물질이 보고되고 있다.Due to these problems, research on natural preservatives having excellent safety and economical efficiency of products is ongoing, and as a result, extracts of animal and vegetable origin such as spices, essential oils, and herbal medicines (Korean Patent Nos. 10-09862490, 10-07876340) No. 10-07825990, No. 10-09814070, No. 10-07298310, No. 10-0822416, No. 10-09428300, No. 2009-0025654, No. 2007-0080707 and No. 2009- 0075282) and natural antimicrobial agents of microbial origin such as bacteriocin have been reported.
그러나, 많은 업체들은 천연 소재의 비싼 가격과 천연 소재에 대한 가공 기술력의 미비 등으로 인하여 천연 소재를 방부제로 사용하지 못하고 있다. 또한, 천연활성 물질들의 경우, 대부분 색취, 안정성 저하, 좁은 항균스펙트럼, 제형상의 문제점, 재연성 등으로 인하여 상용화되지 못하고 있다.However, many companies do not use natural materials as preservatives due to the high price of natural materials and lack of processing technology for natural materials. In addition, in the case of naturally active substances, most of them are not commercialized due to color, deterioration of stability, narrow antibacterial spectrum, problems in formulation, reproducibility, and the like.
이에, 본 발명자들은 여러 천연물 추출물 중 방부 효능을 가지는 천연물 추출물을 개발하고자 예의 노력한 결과, 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물을 혼합하여 사용하는 경우 각각의 천연 추출물에 비하여 미생물 생장 억제효과가 증가하는 것을 확인하고 본 발명을 완성하게 되었다.
Therefore, the present inventors have made efforts to develop a natural product extract having an antiseptic effect among various natural extracts, and when using a mixture of Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje Geun extract inhibits the growth of microorganisms compared to each natural extract It was confirmed that the effect was increased and the present invention was completed.
본 발명의 목적은 천연 방부 및 항균 효과가 뛰어난 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물을 함유하는 천연 복합 방부제 조성물을 제공하는데 있다.
An object of the present invention is to provide a natural composite preservative composition containing Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje Geun extract excellent in natural antiseptic and antibacterial effect.
상기 목적을 달성하기 위하여, 본 발명은 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물을 함유하는 천연 복합 방부제 조성물을 제공한다. In order to achieve the above object, the present invention provides a natural complex preservative composition containing the Tahibo extract, Tobok-ryong extract, the fennel leaf extract and Yangje-Geun extract.
본 발명은 또한, 상기의 천연 복합 방부제 조성물을 방부성분으로 함유하는 화장품을 제공한다. The present invention also provides a cosmetic containing the above-mentioned natural composite preservative composition as an antiseptic component.
본 발명은 또한. 상기의 천연 복합 방부제 조성물을 방부성분으로 함유하는 식품을 제공한다.
The invention also. Provided is a food containing the above-mentioned natural composite preservative composition as an antiseptic component.
본 발명의 천연 복합 방부제 조성물은 인체에 독성이 없으며 뛰어난 방부효과 및 항균 효과를 가지고 있어, 합성 방부제 대신 화장품, 식품 및 의약품의 천연 방부제로 사용될 수 있다.
The natural composite preservative composition of the present invention is not toxic to the human body and has an excellent antiseptic and antimicrobial effect, and can be used as a natural preservative in cosmetics, foods and medicines instead of synthetic preservatives.
도 1은 각각의 균주에 대한 미생물 생장 최소억제농도 평균값과 천연 복합 방부제 조성물의 미생물 생장 최소억제농도를 비교평가한 그림이다. Figure 1 is a comparison of the microbial growth minimum inhibitory concentration average value and the microbial growth minimum inhibitory concentration of the natural complex preservative composition for each strain.
다른 식으로 정의되지 않는 한, 본 명세서에서 사용된 모든 기술적 및 과학적 용어들은 본 발명이 속하는 기술 분야에서 숙련된 전문가에 의해서 통상적으로 이해되는 것과 동일한 의미를 갖는다. 일반적으로 본 명세서에서 사용된 명명법은 본 기술 분야에서 잘 알려져 있고 통상적으로 사용되는 것이다.Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In general, the nomenclature used herein is well known and commonly used in the art.
본 발명의 일관점에서, 본 발명은 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물을 함유하는 천연 복합 방부제 조성물에 관한 것이다. In a consistent aspect of the present invention, the present invention relates to a natural complex preservative composition containing Tahibo extract, Tobok Ryong extract, Bangah Leaf Extract and Yangje Geun Extract.
본 발명에 있어서, 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물의 함량은 각각 0.01 내지 2.0 중량% 인 것을 특징으로 할 수 있다. In the present invention, the content of Tahibo extract, Tobok-ryong extract, Bangalore extract and Yangje-geun extract may be characterized in that each of 0.01 to 2.0% by weight.
상기의 천연 복합 방부제 조성물은 바람직하게는 타히보 추출물 0.2 중량%, 토복령 추출물 0.05 중량%, 방아잎 추출물 0.05 중량% 및 양제근 추출물 0.2 중량%으로 구성될 수 있다. The natural complex preservative composition may preferably be composed of 0.2% by weight of tahibo extract, 0.05% by weight of Tobok-ryong extract, 0.05% by weight of leaf extract and 0.2% by weight of Yangje-Geun extract.
본 발명의 일 실시예에서 건조된 타히보 100g을 분쇄한 후 70%(v/v)에탄올 수용액으로 12시간 가온 환류추출하고 냉침 시키고, 1.2㎛ 투과 사이즈를 갖는 여과지로 여과하여 여과액을 수득하였다. 수득된 여과액을 감압 농축 및 감압 건조로 농축하여 6.87g의 타히보 추출물을 얻었다. In an embodiment of the present invention, 100 g of dried Tahibo was pulverized, and then heated and refluxed with 70% (v / v) ethanol aqueous solution for 12 hours, cooled, and filtered through a filter paper having a permeation size of 1.2 μm to obtain a filtrate. The obtained filtrate was concentrated under reduced pressure and dried under reduced pressure to obtain 6.87 g of Tahibo extract.
본 발명의 다른 실시예에서 건조된 토복령 100g을 분쇄한 후 70%(v/v)에탄올 수용액으로 12시간 가온 환류추출하고 냉침 시키고, 1.2㎛ 투과 사이즈를 갖는 여과지로 여과하여 여과액을 수득하였다. 수득된 여과액을 감압 농축 및 감압 건조로 농축하여 9.65g의 토복령 추출물을 얻었다. In another embodiment of the present invention, 100 g of dried Tobok-ryeong was ground and refluxed with 70% (v / v) ethanol aqueous solution for 12 hours, refrigerated, and filtered through a filter paper having a permeation size of 1.2 μm to obtain a filtrate. . The filtrate obtained was concentrated under reduced pressure and dried under reduced pressure to obtain 9.65 g of Tobok Rin extract.
본 발명의 다른 실시예에서 건조된 방아잎 100g을 분쇄한 후 70%(v/v)에탄올 수용액으로 12시간 가온 환류 추출하고 냉침 시키고, 1.2㎛ 투과 사이즈를 갖는 여과지로 여과하여 여과액을 수득하였다. 수득된 여과액을 감압 농축 및 감압 건조로 농축하여 5.31g의 방아잎 추출물을 얻었다. In another embodiment of the present invention, 100 g of dried dried leaf leaves were pulverized, heated and refluxed with 70% (v / v) ethanol aqueous solution for 12 hours, cooled, and filtered through a filter paper having a permeation size of 1.2 μm to obtain a filtrate. . The filtrate obtained was concentrated under reduced pressure and dried under a reduced pressure to obtain 5.31 g of leaf extract.
본 발명의 다른 실시예에서 건조된 양제근 100g을 분쇄한 후 70%(v/v)에탄올 수용액으로 12시간 가온 환류 추출하고 냉침 시키고, 1.2㎛ 투과 사이즈를 갖는 여과지로 여과하여 여과액을 수득하였다. 수득된 여과액을 감압 농축 및 감압 건조로 농축하여 16.5g의 양제근 추출물을 얻었다. In another embodiment of the present invention, 100 g of dried dried Yangje root was pulverized, heated to reflux for 12 hours with 70% (v / v) ethanol aqueous solution, cooled and cooled, and filtered through a filter paper having a permeation size of 1.2 μm to obtain a filtrate. The obtained filtrate was concentrated under reduced pressure and dried under reduced pressure to obtain 16.5 g of Yangje Geun extract.
상기 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물의 항균력을 측정하기 위해 고체 배양 희석법을 이용하여 최소저해 농도를 측정한 결과, 타히보 추출물의 경우, 그람 양성균인 황색포도상구균과 대장균에 대해 0.1 중량%의 농도에서 우수한 항균활성을 나타냈으나, 그람 양성균인 녹농균에 대해서는 상대적으로 약한 항균활성을 나타냈으며, 캔디다 효모의 경우, 0.2 중량%의 농도에서 우수한 항균활성을 나타내었고, 흑국균에 대해서는 상대적으로 약한 항균활성을 나타내었다. 또한, 토복령 추출물의 경우, 그람 음성균인 대장균과 녹농균에 대해서는 0.1 중량%의 농도에서도 우수한 항균활성을 나타냈으나, 황색포도상 구균, 캔디다 효모 및 흑국균에 대해서 상대적으로 약한 항균활성을 나타냈다. 방아잎 추출물의 경우, 그람음성세균 및 그람양성세균 모두에 대해 약한 항균활성을 나타냈으나, 진균류인 효모와 사상균에 대해 0.05 중량% 농도에서 효과적으로 항균활성을 나타냈다. 양제근 추출물의 경우에도 세균에 대해서 항균활성을 나타냈으나, 사상균에 대한 항균활성이 우수한 것을 확인할 수 있었다 (표 1).As a result of measuring the minimum inhibitory concentration by using a solid culture dilution method to measure the antimicrobial activity of the Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje-geun extract, in the case of Tahibo extract, Gram-positive bacteria Staphylococcus aureus and E. coli 0.1 It showed good antibacterial activity at the concentration of% by weight, but showed relatively weak antibacterial activity against P. aeruginosa, Gram-positive bacteria, and 0.2% by weight of Candida yeast. It showed relatively weak antimicrobial activity. In addition, the extracts of Tobok-ryeong showed good antimicrobial activity against Gram-negative bacteria E. coli and Pseudomonas aeruginosa at a concentration of 0.1% by weight, but showed relatively weak antimicrobial activity against Staphylococcus aureus, Candida yeast and Black Bacillus. In the case of M. leaf extract, it showed weak antimicrobial activity against both Gram-negative bacteria and Gram-positive bacteria, but showed effective antimicrobial activity at 0.05 wt% concentration against fungi yeast and filamentous fungi. In the case of Yangje-geun extract also showed antimicrobial activity against bacteria, it was confirmed that the antimicrobial activity against filamentous fungi was excellent (Table 1).
본 발명의 다른 실시예에서 상기 추출물들을 다양한 비율로 혼합하여 천연 복합 방부제 조성물을 제조하였고(표 2), 제조된 천연 복합 방부제 조성물의 방부력을 확인하기 위해 원형여과지법(paper disc method) 및 미생물 생장 최소억제 농도 평가를 수행한 결과, 천연 복합 방부제는 여러 조합에서 방부 활성을 나타냈으며, 타히보 추출물 0.2 중량%, 토복령 추출물 0.05 중량%, 방아잎 추출물 0.05 중량% 및 양제근 추출물 0.2 중량%로 혼합된 천연 복합 방부제 조성물이 우수한 조합임을 확인할 수 있었다 (표 3 및 표 4).In another embodiment of the present invention by mixing the extracts in various ratios to prepare a natural composite preservative composition (Table 2), to determine the antiseptic power of the prepared natural composite preservative composition (paper disc method) and microorganisms As a result of evaluation of growth inhibition concentration, the natural complex preservative showed antiseptic activity in various combinations, mixed with 0.2% by weight of tahibo extract, 0.05% by weight of Tobokyeong extract, 0.05% by weight of leaf extract and 0.2% by weight of Yangje-Geun extract. It was confirmed that the natural composite preservative composition was an excellent combination (Table 3 and Table 4).
상기의 천연 복합 방부제 조성물에 함유된 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물은 항균 및 방부효능은 이미 보고가 되어있으나, 본 발명의 일부 실시예에서와 같이 각각의 추출물들은 그람양성균, 그람음성균, 진균류 모두에서 뛰어난 항균활성을 보이지 못하므로 사용범위에 제한성이 있다. 하지만 본 발명의 천연 복합 방부제 조성물은 그람양성균, 그람음성균 및 진균류 모두에서 뛰어난 항균활성으로 보이며 각각의 균주에 대한 미생물 생장 최소억제농도 평균값과 시험예 6을 비교한 결과, 시험예 6의 비율로 혼합하여 사용한 경우 각각의 평균값보다 70~80% 감소된 미생물 생장 최소억제 농도 값을 보여 뛰어난 미생물 생장 억제 효과를 확인할 수 있었다 (표 5 및 도 1). 즉, 각각의 추출물을 따로 사용하였을 때보다 본 발명에서와 같이 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물을 일정한 비율로 혼합하여 사용하였을 때 상승적인 미생물 생장 억제 효과(synergy effect)를 보이는 것을 확인하였다. Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje Geun extract contained in the natural complex antiseptic composition has already been reported antibacterial and antiseptic effect, as in some embodiments of the present invention, each extract is Gram-positive bacteria, Gram-negative bacteria and fungi do not show excellent antimicrobial activity, so the range of use is limited. However, the natural composite preservative composition of the present invention appears to be excellent antimicrobial activity in both Gram-positive bacteria, Gram-negative bacteria and fungi, and compared with the average microbial growth minimum inhibitory concentration value for each strain and Test Example 6, mixed in the ratio of Test Example 6 When used to show the microbial growth inhibitory concentration value 70 ~ 80% less than the average value of each was able to confirm the excellent microbial growth inhibitory effect (Table 5 and Figure 1). In other words, when used in combination with the Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje Geun extract in a constant ratio as in the present invention than when using each extract separately showing a synergistic microbial growth inhibitory effect (synergy effect) It was confirmed.
본 발명의 천연 복합 방부제 조성물의 독성을 확인하기 위해 상기 조합의 복합 천연 방부제 조성물을 이용하여 세포 독성을 확인한 결과, 5 중량%의 복합천연방부제 조성물을 처리하였을 때, HaCaT 세포 및 HDF-N 세포에서 각각 90.1% 및 91.2%의 생존율을 보이는 것을 확인하였으며, 천연 복합 방부제 조성물의 방부 활성이 1 중량% 내외에서 효과적으로 나타나므로 화장용 조성물, 식품 및 의약품 제형에 안전하게 사용할 수 있음을 확인하였다 (표 6 및 표 7).In order to confirm the toxicity of the natural composite preservative composition of the present invention, the cytotoxicity was confirmed by using the composite natural preservative composition of the combination, when treated with 5% by weight of the composite natural preservative composition, in HaCaT cells and HDF-N cells It was confirmed that the survival rate of 90.1% and 91.2%, respectively, and the antiseptic activity of the natural complex preservative composition is effectively shown in about 1% by weight, it was confirmed that it can be safely used in cosmetic compositions, food and pharmaceutical formulations (Table 6 and Table 7).
본 발명의 다른 관점에서, 본 발명은 상기의 천연 복합 방부제 조성물을 방부성분으로 함유하는 화장품에 관한 것이다. In another aspect of the present invention, the present invention relates to a cosmetic containing the above-mentioned natural composite preservative composition as an antiseptic component.
본 발명에 있어서, 상기 화장품의 천연 복합 방부제 조성물의 함량은 0.001 내지 10 중량%인 것을 특징으로 할 수 있다. In the present invention, the content of the natural composite preservative composition of the cosmetic may be characterized in that 0.001 to 10% by weight.
본 발명의 다른 실시예에서 상기의 다양한 비율로 혼합된 천연 복합 방부제 조성물을 이용하여 크림 제형을 제조하였으며(표 8), 천연 복합 방부제를 포함한 제형의 방부력을 확인한 결과, 타히보 추출물 0.2 중량%, 토복령 추출물 0.05 중량%, 방아잎 추출물 0.05 중량% 및 양제근 추출물 0.2 중량%로 혼합된 천연 복합 방부제 조성물을 이용한 제형에서 우수한 방부 효능을 가지는 것을 확인할 수 있었다 (표 9). In another embodiment of the present invention, a cream formulation was prepared using the natural complex preservative composition mixed in the above various ratios (Table 8), and as a result of confirming the preservative strength of the formulation including the natural complex preservative, Tahibo extract 0.2% by weight, It was confirmed that the formulation with the natural complex preservative composition mixed with 0.05% by weight of Tobokyeong extract, 0.05% by weight of leaf extract and 0.2% by weight of Yangje root extract (Table 9).
본 발명의 천연 복합 방부제를 포함한 제형의 피부자극 정도를 확인하기 위해 상기 조합의 천연 복합 방부제를 포함한 제형을 이용하여 건강한 성인 남녀 20명을 대상으로 피부자극 실험을 진행한 결과, 대부분 자극이 없거나 경미한 정도였으며, 화학성분의 방부제가 포함된 크림보다 평균 자극지수가 낮은 것을 확인할 수 있었다 (표 10 및 표 11). In order to confirm the skin irritation degree of the formulation containing the natural complex preservative of the present invention, the skin irritation experiments were conducted in 20 healthy adults and men and women using the formulation including the natural complex preservative in the above combination, and most of them were mild or mild. The average irritation index was lower than that of the cream containing the chemical preservative (Table 10 and Table 11).
또한, 다양한 비율로 혼합된 천연 복합 방부제 조성물을 이용하여 제조된 크림 제형의 안정성을 확인한 결과, 로션이 분리되는 과정인 크리밍, 응집과 같은 현상은 관찰되지 않았으며, 로션 성분의 산화에 의한 특이취도 나타나지 않는 것을 확인하였다 (표 12).In addition, as a result of confirming the stability of the cream formulation prepared using a natural complex preservative composition mixed in various ratios, the phenomenon such as creaming, agglomeration, which is a process of separating the lotion, was not observed. It was confirmed that no odor appeared (Table 12).
본 발명의 또 다른 관점에서, 본 발명은 상기의 천연 복합 방부제 조성물을 방부성분으로 함유하는 식품에 관한 것이다. In still another aspect of the present invention, the present invention relates to a food containing the above-mentioned natural composite preservative composition as an antiseptic component.
상기 천연 복합 방부제 조성물은 식품 및 의약품에 보존제로 사용될 수 있다. The natural complex preservative composition may be used as a preservative in foods and pharmaceuticals.
상기 천연 복합 방부제 조성물은 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물에 추가로 동일 또는 유사한 기능을 나타내는 유효성분을 1종 이상 함유할 수 있다. The natural complex preservative composition may further contain one or more active ingredients exhibiting the same or similar functions in addition to the Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje Geun extract.
본 발명의 천연 복합 방부제 조성물을 유효성분으로 함유하는 화장료 조성물로 제조되는 화장품은 일반적인 유화 제형 및 가용화 제형의 형태로 제조할 수 있으며, 유화 제형의 화장품으로는 영양화장수, 크림, 에센스 등이 있으며, 가용화 제형의 화장품으로는 유연화장수가 있다. Cosmetics prepared with a cosmetic composition containing the natural complex preservative composition of the present invention as an active ingredient may be prepared in the form of a general emulsion formulation and solubilized formulation, cosmetics of the emulsion formulations include nutrient cosmetics, creams, essences, etc. Cosmetics of solubilized formulations include soft cosmetics.
본 발명의 천연 복합 방부제 조성물을 유효성분으로 함유하는 화장료 조성물의 제형으로는 스킨로션, 스킨 소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 맛사지크림, 영양크림, 모이스처 크림, 핸드크림, 에센스, 영양에센스, 팩, 비누, 샴푸, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션, 바디클렌저, 유액, 프레스파우더, 루스파우더, 아이섀도 등의 제형으로 제조될 수 있고, 통상적인 화장료 제조법에 적용시킬 수 있다. 구제척으로 액상, 크림상, 페이스트상 및 고체상등 다양한 성상으로 적용이 가능하며, 이들 각 제형에 적합하고 당업계에 주지된 각종의 통상적인 보조제와 담체를 포함할 수 있다.
Formulation of the cosmetic composition containing the natural complex preservative composition of the present invention as an active ingredient skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, massage cream, nutrition cream, moisture cream, Hand Cream, Essence, Nutrition Essence, Pack, Soap, Shampoo, Cleansing Foam, Cleansing Lotion, Cleansing Cream, Body Lotion, Body Cleanser, Latex, Press Powder, Loose Powder, Eye Shadow, etc. It can be applied to cosmetic preparations. Relief can be applied in various forms such as liquid, cream, paste and solid, and may include various conventional auxiliaries and carriers suitable for each of these formulations and well known in the art.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these examples are for illustrative purposes only and that the scope of the present invention is not construed as being limited by these examples.
실시예Example 1. One. 타히보Tahibo 추출물의 제조 Preparation of extract
건조 중량 100g의 분쇄한 타히보를 70% (V/V) 에탄올 수용액으로 12시간 가온 환류추출하고 냉침한 후, 1.2㎛ 투과사이즈를 갖는 여과지로 여과하였다. 이 여과된 추출액을 50℃이하에서 감압농축한 후 감압건조기를 이용해 완전히 건조시켜 타히보 추출물 6.87g을 수득하였다.
The dried tahibo, which had a dry weight of 100 g, was refluxed for 12 hours with 70% (V / V) ethanol aqueous solution, cooled down, and filtered through a filter paper having a permeation size of 1.2 μm. The filtered extract was concentrated under reduced pressure at 50 ° C. or lower and completely dried using a reduced pressure dryer to obtain 6.87 g of Tahibo extract.
실시예Example 2. 2. 토복령Tobok Spirit 추출물의 제조 Preparation of extract
건조 중량 100g의 분쇄한 연잎을 70% (V/V) 에탄올 수용액으로 12시간 가온 환류추출하고 냉침한 후, 1.2㎛ 투과사이즈를 갖는 여과지로 여과하였다. 이 여과된 추출액을 50℃이하에서 감압농축한 후 감압건조기를 이용해 완전히 건조시켜 토복령 추출물 9.65g을 수득하였다.
The dried lotus leaf having a dry weight of 100 g was heated to reflux for 12 hours with 70% (V / V) ethanol aqueous solution, and then cooled and then filtered through a filter paper having a permeation size of 1.2 μm. The filtered extract was concentrated under reduced pressure at 50 ° C. or lower, and dried completely using a reduced pressure dryer to obtain 9.65 g of Tobok-ryong extract.
실시예Example 3. 3. 방아잎 추출물의 제조Preparation of Membrane Leaf Extract
건조 중량 100g의 분쇄한 방아잎을 70% (V/V) 에탄올 수용액으로 12시간 가온 환류추출하고 냉침한 후, 1.2㎛ 투과사이즈를 갖는 여과지로 여과하였다. 이 여과된 추출액을 50℃이하에서 감압농축한 후 감압건조기를 이용해 완전히 건조시켜 방아잎 추출물 5.31g을 수득하였다.
The dried crushed leaf of 100 g of dry weight was refluxed for 12 hours with an aqueous 70% (V / V) ethanol solution and cooled down, and then filtered through a filter paper having a permeation size of 1.2 μm. The filtered extract was concentrated under reduced pressure at 50 ° C. or lower and dried completely using a reduced pressure dryer to obtain 5.31 g of leaf extract.
실시예Example 4. 4. 양제근Yang Jae-geun 추출물의 제조 Preparation of extract
건조 중량 100g의 분쇄한 양제근을 70% (V/V) 에탄올 수용액으로 12시간 가온 환류추출하고 냉침한 후, 1.2㎛ 투과사이즈를 갖는 여과지로 여과하였다. 이 여과된 추출액을 50℃이하에서 감압농축한 후 감압건조기를 이용해 완전히 건조시켜 양제근 추출물 16.5g을 수득하였다.
100 g of dried ginseng root was dried and refluxed for 12 hours with an aqueous 70% (V / V) ethanol solution, and then cooled and filtered through a filter paper having a permeation size of 1.2 μm. The filtered extract was concentrated under reduced pressure at 50 ° C. or lower, and then dried completely using a reduced pressure dryer to obtain 16.5 g of Yangje-Geun extract.
실험예Experimental Example 1. 미생물 생장 최소 억제 농도 측정 1. Measurement of the minimum inhibitory concentration of microbial growth
상기 추출물들의 항균 효과를 측정하기 위하여 최소 저해농도(Minimum Inhibition Concentration, MIC)를 측정하여 항균활성을 조사하였다. 항균 효과를 측정하기 위하여 사용한 균주로는 그람양성균으로 포도상구균(Staphylococcusaureus ATCC 6538P), 그람음성균으로 대장균(Escherichia coli ATCC 8739), 녹농균(Pseudomonas aeruginosa ATCC 9027), 효모로는 캔디다 효모(Candida albicans ATCC 10231), 사상균으로 흑국균(Aspergillus niger ATCC22343)을 한국생명공학연구원 생물자원센타(KCTC, Korea)로부터 분양받아 사용하였다.In order to measure the antimicrobial effect of the extracts were investigated by measuring the minimum inhibitory concentration (Minimum Inhibition Concentration, MIC). The strains used to measure the antimicrobial effect were Gram-positive bacteria, Staphylococcusaureus ATCC 6538P, and Gram-negative bacteria, Escherichia. coli ATCC 8739), Pseudomonas aeruginosa ATCC 9027) Candida yeast ( Candyda) albicans ATCC 10231), Aspergillus niger ATCC22343 was used as a filamentous fungus from the Korea Institute of Biotechnology and Biotechnology Center (KCTC, Korea).
각각의 균주는 영양배지(Nutrient Broth) 용액을 제조하여 121℃에서 15분간 멸균한 후 각각의 배양된 균주 1 백금이를 영양배지 용액 (10㎖)에 접종하고, 진탕배양기(shaking incubator)에서 24시간 배양하여 항균실험을 위한 균주를 준비하였다.Each strain prepared a nutrient broth solution and sterilized at 121 ° C. for 15 minutes, and then inoculated each cultured strain 1 platinum into a nutrient solution (10 ml), and in a shaking incubator. Strains were prepared for the antimicrobial experiment by time incubation.
미생물 균주의 성장을 억제하는 항생물질의 최소억제농도를 측정하기 위해, 멸균된 배지에 배양된 균주를 세균은 1 X 106 cfu/㎖, 진균은 1 X 105 cfu/㎖이 되도록 각각을 접종하여 세균의 경우 35℃에서 2일간 배양하고, 진균류의 경우 25℃에서 5일간 배양하여 이를 대조군으로 하여 관찰하였다.In order to measure the minimum inhibitory concentration of antibiotics that inhibit the growth of microbial strains, the strains inoculated in sterile medium were inoculated so that the bacteria were 1 × 10 6 cfu / ml and the fungi were 1 × 10 5 cfu / ml. The bacteria were incubated at 35 ° C. for 2 days, and the fungus was incubated at 25 ° C. for 5 days and observed as a control.
한편, 각각의 추출물은 0.01 내지 1 중량%가 되도록 배지에 첨가하여 제조한 후 제균하여 대조군과 마찬가지로 세균은 1 X 106 cfu/㎖, 진균은 1 X 105 cfu/㎖이 되게 각각 접종하여 세균의 경우 35℃에서 2일간 배양하고, 진균류의 경우 25℃에서 5일간 배양하여 이를 실험군으로 하여 관찰하였다. On the other hand, each extract is prepared by adding to the medium to 0.01 to 1% by weight, and then sterilized and inoculated to bacteria 1 X 10 6 cfu / ㎖, fungi 1 X 10 5 cfu / ㎖ as in the control group In the case of incubation for 2 days at 35 ℃, for 5 days at 25 ℃ for fungi were observed as an experimental group.
배양이 끝난 대조군과 실험군의 배지 용액에 대해서 각 균주의 증식 유무를 확인하기 위하여 무균공간에서 시료를 약 300㎕씩 취하여 멸균된 96웰 마이크로플레이트에 분주하고 분광 광도계(spectrophotometer)를 이용하여 650nm에서 흡광도를 측정하여 미생물의 증식을 확인하였고 대조군과 비교하여 각각의 균주에 대하여 낮은 증식도를 보인 최소 농도를 측정하여 이를 최소저해농도(Minimum inhibitory concentration,MIC)로 하였다.
In order to confirm the growth of each strain in the culture solution of the control group and the experimental group, approximately 300 µl of the sample was collected in a sterile space and dispensed into sterile 96-well microplates and absorbance at 650 nm using a spectrophotometer. The microbial proliferation was confirmed by measuring and the minimum concentration showing the low proliferation of each strain was compared with the control group, and the minimum inhibitory concentration (MIC) was determined.
타히보 추출물의 경우, 그람 양성균인 황색포도상구균과 대장균에 대해 0.1중량%의 농도에서 우수한 항균활성을 나타냈으나, 그람 양성균인 녹농균에 대해서는 상대적으로 약한 항균활성을 나타냈으며, 또한 캔디다효모의 경우, 0.2 중량%의 농도에서 우수한 항균활성을 나타내었으며, 흑국균에 대해서는 상대적으로 약한 항균활성을 나타내었다.Tahibo extract showed good antimicrobial activity at the concentration of 0.1% by weight against Gram-positive Staphylococcus aureus and Escherichia coli, but relatively weak antimicrobial activity to Gram-positive bacteria Pseudomonas aeruginosa. It showed excellent antimicrobial activity at the concentration of 0.2% by weight, and relatively weak antimicrobial activity against Black Bacillus.
토복령 추출물의 경우, 그람 음성균인 대장균과 녹농균에 대해서는 0.1 중량%의 농도에서도 우수한 항균활성을 나타냈으나, 그람양성세균인 황색포도상 구균, 캔디다 효모 및 흑국균에 대해서 상대적으로 약한 항균활성을 나타냈다.Tobokyeong extract showed good antimicrobial activity against Gram-negative Escherichia coli and Pseudomonas aeruginosa at 0.1% by weight, but showed relatively weak antimicrobial activity against Gram-positive bacteria such as Staphylococcus aureus, Candida yeast and Black Bacillus. .
방아잎 추출물의 경우, 그람음성세균 및 그람양성세균 모두에 대해 약한 항균활성을 나타냈으나, 진균류인 효모와 사상균에 대해 0.05 중량% 농도에서 효과적으로 항균활성을 나타냈다. 양제근 추출물의 경우에도 세균에 대해서는 약한 항균활성을 나타냈으나, 사상균에 대한 항균활성이 우수한 것을 확인할 수 있었다( 표 1).
In the case of M. leaf extract, it showed weak antimicrobial activity against both Gram-negative bacteria and Gram-positive bacteria, but showed effective antimicrobial activity at 0.05 wt% concentration against fungi yeast and filamentous fungi. In the case of Yangje-geun extract, it showed weak antimicrobial activity against bacteria, but it was confirmed that the antimicrobial activity against filamentous fungi was excellent (Table 1).
실시예Example 5. 천연 복합 방부제의 제조 5. Preparation of Natural Complex Preservatives
본 발명의 천연 복합 방부제 조성물의 방부 효과를 확인하기 위해 다양한 비율로 혼합된 천연 복합 방부제 조성물을 시험예 1~6와 같이 제조하였다 (표 2).
In order to confirm the antiseptic effect of the natural composite preservative composition of the present invention, a natural composite preservative composition mixed in various ratios was prepared as in Test Examples 1 to 6 (Table 2).
실험예Experimental Example 2. 다양한 비율로 혼합된 천연 복합 방부제 조성물의 방부활성 측정 2. Determination of Antiseptic Activity of Natural Complex Preservative Compositions Mixed at Various Ratios
상기 실시예 5에서 제조한 시험예 1~6의 천연 복합 방부제 조성물의 방부활성을 측정하기 위해 천연 복합 방부제의 최종 농도는 0.01%가 되게 하여 실험을 수행하였다. 시험 방법으로 원형여과지법(paper disc method)을 이용하였으며, 사용한 균주로는 그람양성균으로 포도상구균(Staphylococcusaureus , ATCC 6538P), 그람음성균으로 대장균(Escherichia coli , ATCC 8739), 녹농균(Pseudomonas aeruginosa , ATCC 9027), 효모로는 캔디다 효모(Candida albicans , ATCC 10231), 사상균으로 흑국균(Aspergillus niger , ATCC22343)을 사용하였다.In order to measure the antiseptic activity of the natural composite preservative composition of Test Examples 1 to 6 prepared in Example 5, the experiment was performed so that the final concentration of the natural composite preservative was 0.01%. It used a circular filter paper method (paper disc method) as the test method, using Staphylococcus aureus to Gram-positive bacteria is a strain (Staphylococcusaureus, ATCC 6538P), E. coli gram-negative bacteria (Escherichia coli , ATCC 8739), Pseudomonas aeruginosa , ATCC 9027), candida albicans , ATCC 10231), Aspergillus niger , ATCC22343).
배양한 각각의 균주를 응고된 평판 배지 위에 약 100㎕를 가하여 평판배지에 분주하고 스프레더(spreader)를 이용하여 균일하게 도말 하였다. 측정하고자 하는 각 추출물을 지름이 10mm인 페이퍼디스크(paper disk)에 약 60㎕를 흡수시킨 후 용매를 건조시키고 균주가 도말된 배지 표면상에 밀착시켜 25℃ ~ 35 ℃조건의 배양기에서 48시간 이상 배양 후 페이퍼디스크 주변에 형성된 투명환 (clear zone)의 크기를 측정하여 항균효과를 확인하였다. 그 결과, 천연 복합 방부제는 여러 조합에서 방부 활성을 나타냈으며, 시험예 6의 천연 복합 방부제 조성물이 우수한 조합임을 확인할 수 있었다 (표 3).
About 100 μl of each of the cultured strains was added to the coagulated plate medium, which was dispensed into plate medium and spread evenly by using a spreader. After absorbing about 60 µl of each extract to be measured on a 10 mm diameter paper disk, the solvent was dried and adhered to the surface of the medium on which the strain was smeared. After incubation, the antimicrobial effect was confirmed by measuring the size of the clear zone formed around the paper disc. As a result, the natural composite preservative showed antiseptic activity in various combinations, it was confirmed that the natural composite preservative composition of Test Example 6 is an excellent combination (Table 3).
실험예Experimental Example 3. 천연 복합 방부제의 미생물 생장 최소억제농도 평가 3. Evaluation of Minimum Inhibitory Concentration of Microbial Growth of Natural Complex Preservatives
천연 복합 방부제의 미생물 생장 최소억제 농도 평가(minimum Inhibition Concentration: MIC)를 측정하기 위해 실험예 1에서와 같은 방법으로 실험을 진행하였다. 그 결과, 시험예 1~6에서 전반적으로 우수한 항균활성을 나타내는 것을 확인하였으며, 시험예 6의 경우 그람 양성균인 황색 포도상 구균에서 0.1 중량%의 농도에서 우수한 항균활성을 나타내었으며, 그람 음성균인 대장균과 녹농균, 캔디다균 및 흑국균에서 0.05 내지 0.08중량% 농도에서 우수한 항균활성을 나타내었다 (표 4). In order to measure the minimum microbial growth inhibition concentration (MIC) of the natural complex preservatives, the experiment was conducted in the same manner as in Experimental Example 1. As a result, it was confirmed that the overall excellent antimicrobial activity in Test Examples 1 to 6, in the case of Test Example 6 showed excellent antimicrobial activity at a concentration of 0.1% by weight of Gram-positive Staphylococcus aureus, E. coli and Gram-negative bacteria Pseudomonas aeruginosa, Candida and Black Bacillus showed excellent antimicrobial activity at a concentration of 0.05 to 0.08% by weight (Table 4).
또한, 각각의 균주에 대한 미생물 생장 최소억제농도 평균값과 시험예 6을 비교한 결과, 시험예 6의 비율로 혼합하여 사용한 경우 각각의 평균값보다 70~80% 감소된 미생물 생장 최소억제 농도를 보여 뛰어난 미생물 생장 억제 효과를 확인할 수 있었다 (표 5 및 도 1). 즉, 각각의 추출물을 따로 사용하였을 때보다 본 발명에서와 같이 타히보 추출물, 토복령 추출물, 방아잎 추출물 및 양제근 추출물을 일정한 비율로 혼합하여 사용하였을 때 상승적인 미생물 생장 억제 효과(synergy effect)를 보이는 것을 확인하였다.
In addition, as a result of comparing the average microbial growth inhibitory concentration value and Test Example 6 for each strain, when used in a mixture of Test Example 6 ratio showed a microbial growth minimum inhibitory concentration is reduced 70 ~ 80% than the average value of each Microbial growth inhibitory effect was confirmed (Table 5 and FIG. 1). In other words, when used in combination with the Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje Geun extract in a constant ratio as in the present invention than when using each extract separately showing a synergistic microbial growth inhibitory effect (synergy effect) It was confirmed.
실험예Experimental Example 5. 5. 천연 복합 방부제의 세포독성 평가Cytotoxicity Assessment of Natural Complex Preservatives
천연 복합 방부제의의 독성을 확인하기 위해, 상기 실험예에서 가장 방부활성이 높은 시험예 6을 이용하여 HaCaT cell과 HDF-N cell에서의 세포독성을 측정하였다. HaCaT cell은 96 well plate에 well 당 5 × 104 cell의 농도로, HDF-N cell은 96 well plate에 well 당 6 × 103 cell의 농도로 분주한 다음 세포 배양조건에서 24시간 배양하였다. 배지를 제거하고 DPBS로 세척한 뒤, 12시간의 기아상태를 유지시킨 후 검액 및 새로운 배지(media supplement 제외)를 넣고, 24시간 배양하였다. 또 검액 및 배지를 제거하고 PBS로 세척한 후, 세포의 생존율을 측정하기 위해 WST-1 반응액을 supplement가 제외된 배지에 1/10로 희석하고 이를 각 well당 100 ㎕씩 처리하여 1시간 반응시킨 후, 450 nm에서 흡광도를 측정하였다.In order to confirm the toxicity of the natural complex preservatives, cytotoxicity was measured in HaCaT cells and HDF-N cells using Test Example 6 having the highest antiseptic activity in the above experimental examples. HaCaT cells were dispensed at a concentration of 5 × 10 4 cells per well in a 96 well plate, and HDF-N cells were dispensed at a concentration of 6 × 10 3 cells per well in a 96 well plate and incubated in cell culture conditions for 24 hours. After the medium was removed and washed with DPBS, starvation was maintained for 12 hours, sample solution and fresh medium (except for media supplement) were added, and cultured for 24 hours. After removing the sample solution and the medium and washing with PBS, in order to measure the survival rate of the cells, the WST-1 reaction solution was diluted 1/10 in the medium without supplement and treated with 100 μl of each well for 1 hour. After the absorbance was measured at 450 nm.
그 결과, HaCaT 세포 및 HDF-N 세포에서 각각 90.1% 및 91.2%의 생존율을 보이는 것을 확인하였으며, 천연 복합 방부제 조성물의 방부 활성이 1% 내외에서 효과적으로 나타나므로 화장용 조성물, 식품 및 의약품 제형에 안전하게 사용할 수 있음을 확인하였다 (표 6 및 표 7).
As a result, it was confirmed that the survival rate of 90.1% and 91.2% in HaCaT cells and HDF-N cells, respectively, and the antiseptic activity of the natural complex preservative composition is effectively shown in about 1%, so it is safe for cosmetic compositions, food and pharmaceutical formulations. It was confirmed that it could be used (Table 6 and Table 7).
Control%
Control
Control%
Control
실시예Example 6. 다양한 비율로 혼합된 천연 복합 방부제를 함유하는 크림 제형 제조 6. Preparation of Cream Formulations Containing Natural Complex Preservatives Mixed in Various Ratios
본 발명의 천연 복합 방부제 조성물을 함유하는 화장품의 방부력 시험을 행하기 위해 다양한 비율로 혼합된 천연 복합 방부제 조성물이 함유된 크림 제형을 비교예 1 및 시험예 1~6와 같이 제조하였다 (표 8).
In order to perform an antiseptic test of a cosmetic containing a natural composite preservative composition of the present invention, a cream formulation containing a natural complex preservative composition mixed in various ratios was prepared as Comparative Examples 1 and 1 to 6 (Table 8). ).
실험예Experimental Example 5. 천연 복합 방부제를 함유한 제형의 방부 효과 확인 5. Confirmation of Preservative Effect of Formulations Containing Natural Complex Preservatives
비교예 1과 시험예 1~6에 대한 방부 효과를 미국화장품공업협회(The Cosmetic, Toility and Fragrance Association, Inc., 이하 CTFA)의 미생물 가이드라인(microbiology Guidelines)의 시험법을 사용하여 행하였다. 사용한 균주로는 그람양성균으로 포도상구균(Staphylococcusaureus , ATCC 6538P), 그람음성균으로 대장균(Escherichia coli , ATCC 8739), 녹농균(Pseudomonas aeruginosa , ATCC 9027), 효모로는 캔디다 효모(Candida albicans , ATCC 10231), 사상균으로 흑국균(Aspergillus niger , ATCC22343)을 사용하였다. 비교예와 시험예들이 10g씩 담겨져 있는 병에 세균 3종(E. coli , P. aeruginosa , S. aureus)과 진균 2종(C. albicans, A. niger)을 혼합한 현탁액을 각각 1×106cfu/g, 1×105cfu/g이 되도록 접종한 다음, 25℃에서 보관 후 4시간, 1일, 2일, 3일, 7일 간격으로 무균 조작 하에서 1g의 샘플을 채취하여 희석액으로 적절히 희석하고 세균은 뉴트리언트 아가(Nutrient agar, Difco), 진균은 포테이토 덱스트로스 아가(potato dextrose agar, Difoc) 배지에 깔아 각각 35℃, 25℃에서 24 ~ 72시간 동안 배양 후 계수하였다. 그 결과, 시험예 6의 복합 천연 방부제를 함유한 크림의 방부 효과는 종래의 합성 방부제로 사용되는 비교예와 비슷한 효과를 보이므로(표 9), 본 발명의 천연 복합 방부제 조성물을 매우 우수한 방부 효과를 가지는 것을 확인하였다.
The antiseptic effect on Comparative Example 1 and Test Examples 1 to 6 was performed using the test method of microbiology guidelines of The Cosmetic, Toility and Fragrance Association, Inc. (hereinafter referred to as CTFA). Staphylococcus aureus with a gram-positive bacteria is a strain (Staphylococcusaureus, ATCC 6538P), E. coli gram-negative bacteria (Escherichia coli , ATCC 8739), Pseudomonas aeruginosa , ATCC 9027), candida albicans , ATCC 10231), Aspergillus niger , ATCC22343). In a bottle containing 10 g of Comparative Examples and Test Examples , a suspension of three bacteria ( E. coli , P. aeruginosa , S. aureus ) and two fungi ( C. albicans, A. niger ) was mixed. Inoculate 6 cfu / g, 1 × 10 5 cfu / g, and store 1 g of the sample under aseptic operation at 4 hours, 1 day, 2 days, 3 days, and 7 days after storage at 25 ° C. Properly diluted, bacteria were cultured in Nutrient agar (Difco) and fungi in Potato dextrose agar (Difoc) medium and counted after incubation at 35 ° C and 25 ° C for 24 to 72 hours, respectively. As a result, since the antiseptic effect of the cream containing the composite natural preservative of Test Example 6 shows an effect similar to that of the comparative example used as a conventional synthetic preservative (Table 9), the natural composite preservative composition of the present invention is very excellent antiseptic effect. It was confirmed to have.
실험예Experimental Example 6. 천연 복합 방부제의 피부자극 실험 6. Skin irritation test of natural complex preservative
천연 복합 방부제의 피부자극 실험을 위해 상기 실시예 6에서 시행한 크림 제형의 시험예 6의 천연방부제 조성으로 피부자극 실험을 진행하였다.The skin irritation test was carried out with the natural preservative composition of Test Example 6 of the cream formulation carried out in Example 6 for the skin irritation test of the natural complex preservative.
건강한 성인 남녀 20명을 대상으로 CTFA 가이드라인 (The Cosmetic, Toility and Fragrance Association, Inc. Washington D.C., 20036, 1991)에 따라 실시하였다. 핀 쳄버(finn chamber)에 시료 및 용액 15㎎/15㎕를 적하시킨 후, 이것을 시험 부위인 인체의 팔에 얹어 테이프로 고정시켰다. 이어서 24시간 동안 첩포한 후, 첩포를 제거하고 다시 2시간 경과한 다음 시험 부위의 피부 반응을 다음 기준에 따라 판정한 결과, 대부분 자극이 없거나 경미한 정도였으며, 화학성분의 방부제가 포함된 크림보다 평균 자극지수가 낮은 것을 확인할 수 있었다 (표 10 및 표 11).
Twenty healthy men and women were tested according to CTFA guidelines (The Cosmetic, Toility and Fragrance Association, Inc. Washington DC, 20036, 1991). 15 mg / 15 μl of the sample and the solution were added dropwise to a pin chamber, and it was placed on the arm of the human body as a test site and fixed with tape. Subsequently, after 24 hours of patching, the patch was removed and after 2 hours, the skin reaction at the test site was judged according to the following criteria, which was mostly irritating or mild and averaged over creams containing chemical preservatives. It was confirmed that the stimulation index is low (Table 10 and Table 11).
(0.5% 방부처방크림)Test Example 6
(0.5% Preservative Prescription Cream)
(무방부크림처방)Control group
(Mbangbang cream prescription)
실험예Experimental Example 7. 제형의 안정성 실험 7. Stability Test of Formulation
천연 복합 방부제 조성물을 함유하는 실시예 6의 시험예 1~6의 크림과 천연 복합 방부제조성물을 함유하지 않은 크림(대조군)을 12주 동안 온도(0, 25, 37, 45, 일광)를 다르게 하여 저장한 후 크림의 육안관찰 및 냄새들의 변화를 관찰하였다. 그 결과, 대조군과 시험예 1~6을 함유한 크림 모두 12주 동안 로션의 분리가 되는 과정인 크리밍 및 응집과 같은 현상은 관찰되지 않았으며, 로션 성분의 산화에 의한 특이취도 나타나지 않았다 (표 12).
The creams of Test Examples 1-6 of Example 6 containing the natural complex preservative composition and the cream (control) not containing the natural complex preservative composition were changed at different temperatures (0, 25, 37, 45, daylight) for 12 weeks. After storage, visual observation of the cream and changes in smell were observed. As a result, both the control and the cream containing Test Examples 1 to 6 were not observed such as creaming and agglomeration, which are processes of separating the lotion for 12 weeks, and there was no specific odor due to oxidation of the lotion component ( Table 12).
0: 변화없음, 2: 조금 변화, 4: 심하게 변화(변취,변색,분리)
0: no change, 2: slight change, 4: severe change (changing, discoloration, separation)
이상으로, 본 발명 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.As described above, specific parts of the present disclosure have been described in detail, and for those skilled in the art, these specific descriptions are merely preferred embodiments, and the scope of the present disclosure is not limited thereto. Will be obvious. It is therefore intended that the scope of the invention be defined by the claims appended hereto and their equivalents.
Claims (5)
Natural complex preservative composition containing Tahibo extract, Tobokyeong extract, Banga leaf extract and Yangje Geun extract.
The natural composite preservative composition according to claim 1, wherein the tahibo extract, the Tobok-ryong extract, the leaf extract, and the extract of Yangje-Geun are 0.01 to 2.0% by weight, respectively.
Cosmetics containing the natural composite preservative composition of claim 1 or 2 as an antiseptic component.
The cosmetic according to claim 3, wherein the content of the natural composite preservative composition is 0.001 to 10% by weight.
Food containing the natural complex antiseptic composition of Claim 1 or 2 as an antiseptic component.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120053031A KR101356799B1 (en) | 2012-05-18 | 2012-05-18 | Natural preservative composition containing the extract of Tabebuia avellanedae, Smilax chian L., Rumex japonicus and Agastache rugosa |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120053031A KR101356799B1 (en) | 2012-05-18 | 2012-05-18 | Natural preservative composition containing the extract of Tabebuia avellanedae, Smilax chian L., Rumex japonicus and Agastache rugosa |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130128887A KR20130128887A (en) | 2013-11-27 |
KR101356799B1 true KR101356799B1 (en) | 2014-01-29 |
Family
ID=49855880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120053031A KR101356799B1 (en) | 2012-05-18 | 2012-05-18 | Natural preservative composition containing the extract of Tabebuia avellanedae, Smilax chian L., Rumex japonicus and Agastache rugosa |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101356799B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102066821B1 (en) * | 2019-09-06 | 2020-01-15 | 이훈 | Natural Complex Cosmetic Preservative Composition |
KR20230159672A (en) | 2022-05-14 | 2023-11-21 | 정유진 | Atopy, acne, skin irritation improved functional cosmetics containing hydrogen and natural derived preservation substance and their manufacturing method |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101476220B1 (en) * | 2014-04-29 | 2014-12-24 | 주식회사 에스앤텍 | Smilax china extracts the natural preserve of manufacturing method |
KR101960967B1 (en) * | 2017-06-05 | 2019-03-21 | 주식회사 하이원엔시 | A High-strength urn with improved preservability |
WO2019013374A1 (en) * | 2017-07-14 | 2019-01-17 | (주)뉴트리바이오텍 | Method for preparing freeze-dried product of taheebo ethanol extract |
KR102074129B1 (en) | 2018-05-24 | 2020-02-06 | 엘앤피코스메틱(주) | Antiseptic composition comprising the extract from bark of Melia azedarach L. var. japonica Makino, Paeonia lactiflora Pall. and Zanthoxylum piperitum DC and a cosmetic composition comprising the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090025497A (en) * | 2007-09-06 | 2009-03-11 | (주)더페이스샵코리아 | The cosmetics composition being contained pau d'arco, tabebuia avellanedae extracts and having the effects of antiphlogistic and abirritation of skin |
KR20110132002A (en) * | 2010-06-01 | 2011-12-07 | (주)선바이오텍 | Antifungal composition comprising herb extracts, anti-dermatophytosis by using thereof and, method of manufacturing thereof |
-
2012
- 2012-05-18 KR KR1020120053031A patent/KR101356799B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090025497A (en) * | 2007-09-06 | 2009-03-11 | (주)더페이스샵코리아 | The cosmetics composition being contained pau d'arco, tabebuia avellanedae extracts and having the effects of antiphlogistic and abirritation of skin |
KR20110132002A (en) * | 2010-06-01 | 2011-12-07 | (주)선바이오텍 | Antifungal composition comprising herb extracts, anti-dermatophytosis by using thereof and, method of manufacturing thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102066821B1 (en) * | 2019-09-06 | 2020-01-15 | 이훈 | Natural Complex Cosmetic Preservative Composition |
KR20230159672A (en) | 2022-05-14 | 2023-11-21 | 정유진 | Atopy, acne, skin irritation improved functional cosmetics containing hydrogen and natural derived preservation substance and their manufacturing method |
Also Published As
Publication number | Publication date |
---|---|
KR20130128887A (en) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101525976B1 (en) | Natural preservative composition containing Agrimonia Pilosa Extract, Coptis Chinensis Root Extract and Green Tea Extract | |
KR101356799B1 (en) | Natural preservative composition containing the extract of Tabebuia avellanedae, Smilax chian L., Rumex japonicus and Agastache rugosa | |
KR101511747B1 (en) | Natural Preservative Composition Containing the Extract of Lisimachiae Herba, Galla Rhois, Cassia Bark and Caryophylli Flos | |
KR20130128888A (en) | Natural preservative composition containing the extract of nelumbo nucifera leaf, flower, seed and root | |
KR101824687B1 (en) | Antimicrobial composition comprising natural plant extract | |
KR101806800B1 (en) | Complex natural preservative comprising scutellaria baicalensis extract and method manufacture the same | |
KR101634668B1 (en) | Cosmetic composition comprising fermented extract of mistletoe for anti-oxidation or whitening | |
KR102442117B1 (en) | Cosmetic composition for skin improvement comprising Orostachys japonicus extract or mixture of Orostachys japonicus extract and Pachymeniopsis elliptica extract | |
KR100986249B1 (en) | Natural antimicrobial and antiseptic substance made from Dryopteris crassirhizoma root extract complex | |
KR101442083B1 (en) | Cosmetic composition with culture meida of Latobacillus plantarum as antiseptic or functional component | |
KR101694229B1 (en) | Cosmetic composition comprising sacha inchi oil and extract of Portulaca oleracea L. | |
KR102126666B1 (en) | A Natural Preservative Composition Based on a Edible Ingredients for Cosmetic Product | |
KR102102253B1 (en) | Skin external composition having excellent bactericidal activities | |
KR101473925B1 (en) | Antiseptic compositions comprising Magnolia grandiflora extract and cosmetic compositions containing the same | |
KR101507533B1 (en) | Natural preservative composition containing Silver Needle White Tea Extract, Magnolia Obovata Bark Extract and Terminalia Chebula Bark Extract | |
KR102117693B1 (en) | Complex natural antibacterial agent containing rosemary, cinnamon and fatty acid and method for preparing the same | |
KR102394531B1 (en) | Antiseptic containing caprylic/capric glycerides and composition for skin external application containing thereof | |
KR101839612B1 (en) | Natural Preservative Composition Containing Plant Extract Complex as Active Ingredient | |
KR102009604B1 (en) | Antimicrobial composition comprising lonicera japonica extract and magnolia obovata extract | |
CN111297765B (en) | Roxburgh rose extract and antibacterial application thereof | |
CN109806205B (en) | Fructus chebulae immaturus extract and antibacterial application thereof | |
KR20190006285A (en) | Antibacterial composition comprising an extract of schisandra chinesis | |
KR20180031119A (en) | Natural antimicrobial composition and cosmetic composition containing the same | |
KR20130044475A (en) | Anti-microbial effect from boehmeria nivea extract and its applicant | |
KR20110120481A (en) | Natural preservative cosmetic composition containing fermented liquor of kimchi lactic acid bacteria and extract of willow bark as antibacterial ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170124 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180220 Year of fee payment: 5 |